ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy

BACKGROUND: About one in five patients with locally advanced rectal cancer (RC) suffers recurrence or distant metastasis after neoadjuvant therapy. We investigated how cancer stem cell markers change after neoadjuvant therapy and how these markers relate to recurrence. METHODS: Pretreatment biopsies...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Y, Zhou, J, Fang, L, Cai, Y, Ke, J, Xie, X, Huang, Y, Huang, M, Wang, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899780/
https://www.ncbi.nlm.nih.gov/pubmed/24327017
http://dx.doi.org/10.1038/bjc.2013.767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899780/
https://www.ncbi.nlm.nih.gov/pubmed/24327017
http://dx.doi.org/10.1038/bjc.2013.767

Ejemplares similares